BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4372855)

  • 1. Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers.
    Stillström J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):676-86. PubMed ID: 4372855
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased oncogenic potential of SV40-transformed cells grown in diffusion chambers intraperitoneally.
    Stillström J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):687-95. PubMed ID: 4372856
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and immunosensitivity of SV40-transformed cells with different oncogenic potentials.
    Stillström J
    Int J Cancer; 1973 Sep; 12(2):493-501. PubMed ID: 4365094
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
    Ting CC; Rodrigues D; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells.
    Tevethia SS; Butel JS
    Intervirology; 1973; 2(3):200-5. PubMed ID: 4366480
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of tumor growth by immunization of hamsters with x-irradiated SV40-transformed cells].
    Ashkenazi A; Zadik Z
    Harefuah; 1969 Nov; 77(9):376-9. PubMed ID: 4320099
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic manipulation of metastases due to herpesvirus transformed cells.
    Duff R; Doller E; Rapp F
    Science; 1973 Apr; 180(4081):79-81. PubMed ID: 4347994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of two strains of BCG on transplantation immunity to SV40-induced tumors in hamsters.
    Fortner GW; Hanna MG; Coggin JH
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):62-7. PubMed ID: 4373753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunization of hamsters against tumors induced by the SV40 virus].
    Ciobanu Z; Fenyves A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):109-16. PubMed ID: 4328000
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tumor-specific transplantation immunity in hamsters with cell fractions from adenovirus and SV40 tumor cells.
    Coggin JH; Elrod LH; Ambrose KR; Anderson NG
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):328-36. PubMed ID: 4310176
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40 virus-induced tumour specific transplantation antigen in cultured mouse cells.
    Smith RW; Morganroth J; Mora PT
    Nature; 1970 Jul; 227(5254):141-5. PubMed ID: 4316952
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of SV40 virus oncogenesis in hamsters. II. The effect of thymectomy on induction of tumor resistance by SV40-transformed human cells.
    Girardi AJ; Roosa RA
    J Immunol; 1967 Dec; 99(6):1217-20. PubMed ID: 4294651
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumorigenicity and antigenicity of mouse cells infected with Simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients.
    Wright PW; Smith HS; McCoy J
    J Natl Cancer Inst; 1973 Sep; 51(3):951-9. PubMed ID: 4355223
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 19. Transformation of hamster embryo fibroblasts by herpes simplex viruses type 1 and type 2.
    Rapp F; Duff R
    Cancer Res; 1973 Jun; 33(6):1527-34. PubMed ID: 4352391
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.